Comments
Loading...

Coherus BioSciences

CHRSNASDAQ
Logo brought to you by Benzinga Data
$1.39
-0.03-2.11%
At close: -
$1.39
0.000.00%
After Hours: Jan 17, 4:00 PM EDT

Coherus BioSciences (NASDAQ:CHRS) Stock, Earnings Estimates, EPS, And Revenue

Coherus BioSciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Mar 12
EPS Estimate
$-0.180
Quarterly Revenue Estimate
$43.88M
Annual Revenue
(as of Sep 30)
$304.34M

Analyze the earnings history of Coherus BioSciences using advanced sorting and filters.

Data brought to you by Benzinga APIs

Coherus BioSciences (CHRS) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal QuarterDate ReportedActual EPSEstimated EPSSurprise %
Q32024-11-06$-0.01$-0.1291.7 %
Q22024-08-08$-0.14$-0.1612.5 %
Q12024-05-09$-0.32$-0.24-33.3 %
Q42024-03-13$-0.62$-0.12-416.7 %

Coherus BioSciences (CHRS) Revenue

Quarterly Revenue Surprise Amount

Fiscal QuarterDate ReportedActual RevenueEstimated RevenueSurprise %
Q32024-11-06$70.77M$59.23M19.5 %
Q22024-08-08$64.98M$64.16M1.28 %
Q12024-05-09$77.06M$80.25M-3.97 %
Q42024-03-13$91.52M$96.40M-5.06 %

FAQ

Q

When is Coherus BioSciences (NASDAQ:CHRS) reporting earnings?

A

Coherus BioSciences (CHRS) is scheduled to report earnings on March 12, 2025. The last reported earnings were for reported on November 6, 2024 for Q3.

Q

What were the latest earnings per share (EPS) for Coherus BioSciences (NASDAQ:CHRS)?

A

The Actual EPS was $-0.01, which beat the estimate of $-0.12.

Q

What were Coherus BioSciences’s (NASDAQ:CHRS) revenues?

A

The Actual Revenue was $70.8M, which beat the estimate of $59.2M.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch